Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QScout Lab; QScout RLD

K-Number: K230878 · 2023-11-14

Decision Date2023-11-14
Product CodeGKZ
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

QScout Lab; QScout RLD is the device name listed in this FDA 510(k) record. The listed applicant is Ad Astra Diagnostics, Inc.. It received FDA 510(k) clearance on 2023-11-14 under 510(k) number K230878. The device is classified under product code GKZ. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QScout Lab; QScout RLD?

QScout Lab; QScout RLD is a medical device that received FDA 510(k) clearance on 2023-11-14. The listed applicant is Ad Astra Diagnostics, Inc.. The 510(k) number is K230878.

When did QScout Lab; QScout RLD receive FDA 510(k) clearance?

QScout Lab; QScout RLD received FDA 510(k) clearance on 2023-11-14, under 510(k) number K230878.

Who is the listed applicant for QScout Lab; QScout RLD?

The FDA 510(k) record lists Ad Astra Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QScout Lab; QScout RLD?

The FDA product code for QScout Lab; QScout RLD is GKZ.

Related Devices (Code: GKZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.